Overview

Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
To determine the effect and safety of menatetrenone on treatment of postmenopausal osteoporosis comparing with alfacalcidol.
Phase:
Phase 3
Details
Lead Sponsor:
Eisai Co., Ltd.
Treatments:
Alfacalcidol
Hydroxycholecalciferols
Menatetrenone